MASH: Promising Aspects from the Bench

Nov 09 2025
Convention Center: Ballroom A, Level 3
11:00 AM - 12:30 PM

World Class Speakers

Ekihiro Seki, MD, PhD, FAASLD
Abstract Presenter

Ekihiro Seki, MD, PhD, FAASLD

Cedars-Sinai Medical Center
Gyongyi Szabo, MD, PhD, FAASLD
Abstract Presenter

Gyongyi Szabo, MD, PhD, FAASLD

Beth Israel Deaconess Medical Center
Ekihiro Seki, MD, PhD, FAASLD
Moderator

Ekihiro Seki, MD, PhD, FAASLD

Cedars-Sinai Medical Center
Gyongyi Szabo, MD, PhD, FAASLD
Moderator

Gyongyi Szabo, MD, PhD, FAASLD

Beth Israel Deaconess Medical Center

Description

Abstract Parallel sessions feature oral presentations from the authors of highly-rated abstracts submitted for presentation at The Liver Meeting.

Journey Maps

Presentations

11:00 AM - 11:15 AM
May 18 2026
Washington, D.C.

Hepatocyte-macrophage crosstalk rewires liver zonation features in metabolic dysfunction-associated steatotic liver disease (MASLD)  

Ekihiro Seki, MD, PhD, FAASLD , Abstract Presenter
MASLD
11:15 AM - 11:30 AM
May 18 2026
Washington, D.C.

Sexually Dimorphic Palmitoylation of UTY of Liver Sinusoidal Endothelial Cells Drives Advanced Metabolic Dysfunction-Associated Steatohepatitis (MASH) via PGF2α/SPIN1 Axis

Gyongyi Szabo, MD, PhD, FAASLD , Abstract Presenter
MASLD

Objectives

  • Highlight emerging mechanistic insights and molecular pathways implicated in MASH pathogenesis that may inform novel therapeutic targets.
  • Present preclinical data and innovative experimental models contributing to the understanding and future management of MASH.